關於 repatha ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. Repatha (Evolocumab): Second PCSK9 Inhibitor ... - NCBI

Repatha (Evolocumab): Second PCSK9 Inhibitor Approved by the FDA for Patients with Familial Hypercholesterolemia · Evolocumab a PCSK9 Inhibitor for Cholesterol ...

#12. Repatha: Side effects, cost, dosage, generic, and more

Repatha belongs to a class of medications called PCSK9 inhibitors. These drugs help your body remove LDL (“bad”) cholesterol more effectively ...

#13. Repatha (Evolocumab Injection, for Subcutaneous ... - RxList

Repatha is a prescription medicine used to treat the symptoms of reduce the risk of myocardial infarction, stroke and coronary revascularization and Primary ...

#14. Repatha: Side Effects, Cost, Dosage, and More - Healthline

Repatha isn't approved to treat high triglycerides. Rather, it's approved to lower a type of cholesterol called low-density lipoprotein (LDL) in ...

#15. REPATHA (evolocumab) injection, for subcutaneous use

REPATHA is indicated as an adjunct to diet and other LDL-lowering therapies (e.g., statins, ezetimibe,. LDL apheresis) for the treatment of patients with ...

#16. REPATHA Dosage & Rx Info | Uses, Side Effects - eMPR.com

REPATHA prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

#17. Amgen's Repatha gains an edge on rival Praluent with FDA ...

Repatha, which is self-injected every two weeks or monthly, was already approved for another less-common FH condition—homozygous familial ...

#18. Repatha Pushtronex subcutaneous: Uses, Side Effects ...

Evolocumab is used along with a proper diet to help lower "bad" cholesterol (LDL) in the blood. It may be used with other LDL-lowering treatments (such as ...

#19. Repatha Full Prescribing Information, Dosage & Side Effects

Homozygous Familial Hypercholesterolemia: REPATHA is indicated as an adjunct to diet and other LDL-lowering therapies (e.g., statins, ezetimibe, LDL apheresis) ...

#20. Repatha (evolocumab): Basics, Side Effects & Reviews

Repatha (evolocumab) is an expensive injectable medication used to treat high cholesterol and lower the risk of heart attack and stroke.

#21. Evolocumab - Wikipedia

Evolocumab (trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal ...

#22. 膽固醇難控制美通過注射型新藥Repatha - Taiwan News

中央社華盛頓27日綜合外電報導）美國食品暨藥物管理局（FDA）今天通過新型膽固醇藥物Repatha，這是針對頑固型高血脂患者的第2款注射型降血脂藥物，為 ...

#23. Study to Evaluate the Safety of Repatha® in Pregnancy

To evaluate pregnancy and infant outcomes among females diagnosed with familial hypercholesterolaemia (FH), exposed to Repatha® during pregnancy.

#24. Repatha - NPS MedicineWise

Repatha is used with other cholesterol lowering medicines in adults with heart disease to reduce the risk of heart attack, stroke, and certain heart ...

#25. Evolocumab (Repatha) for the Treatment of Hyperlipidemia

Evolocumab (Repatha) is an injectable human monoclonal antibody labeled for decreasing low-density lipoprotein (LDL) cholesterol.

#26. A Second PCSK9 Inhibitor to Lower LDL-Cholesterol - JAMA ...

Evolocumab (Repatha – Amgen), a subcutaneously injected PCSK9 inhibitor, has been approved by the FDA as an adjunct to diet and maximally ...

#27. REPA1 - 藥品資料

廠商名稱：. 藥品中文名稱：, "安進"瑞百安注射液(L). 藥品英文名稱：, (罕)(審)Repatha inj. 140mg/ml/vial(需冷藏)(L). 院內代碼：, REPA1.

#28. Evolocumab and Clinical Outcomes in Patients with ...

In our trial, inhibition of PCSK9 with evolocumab on a background of statin therapy lowered LDL cholesterol levels to a median of 30 mg per ...

#29. F.D.A. Approves Repatha, a Second Drug for Cholesterol in a ...

The new drug, Repatha, made by Amgen, is intended for people with extremely high cholesterol levels and those with heart disease who cannot ...

#30. Repatha® - GuildLink

You should stay on your cholesterol lowering diet and exercise as directed by your doctor while taking this medicine. Repatha contains the active substance.

#31. Repatha - Healthdirect Australia

On this page about Repatha you will find information relating to side effects, age restrictions, food interactions, whether the medicine is available at a ...

#32. Repatha - Uses, Side Effects, Interactions - MedBroadcast.com

Evolocumab belongs to the class of medications called PCSK9 inhibitors. It blocks a protein in the liver, which allows the liver to remove more low-density ...

#33. Repatha Offers Additional LDL-C Reduction in a Convenient ...

... clinical review on the topic of the PCSK9 inhibitor Repatha (evolocumab), and its impact on low-density lipoprotein cholesterol (LDL-C).

#34. 1. REPATHA® (140 mg solution for injection) - Medsafe

alone or in combination with other lipid-lowering therapies in patients who are statin- intolerant. Page 2. NEW ZEALAND DATA SHEET. Repatha – 27 June 2021.

#35. FDA Approves Repatha for Select Patients | HFSA

Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, is approved for use in addition to diet and maximally-tolerated statin ...

#36. Evolocumab (Repatha) Side Effects, Dosage & Interactions

Consumer information about the drug evolocumab (Repatha) prescribed along with diet and exercise to reduce LDL cholesterol in adults with inherited ...

#37. 挑戰賽諾菲/再生元！安進降血脂藥適應症再擴大

美國時間24日，美國食品藥物管理局(FDA)宣布核准安進(Amgen)的降血脂藥Repatha (evolocumab)適應症擴大，從原先僅能用於成人患者，擴大為可治療10歲 ...

#38. Repatha - Amazon.com

Repatha. Prefilled Syringe. FSA or HSA eligible. EVOLOCUMAB (e voe LOK ue mab) treats high cholesterol. It is used with lifestyle changes, like diet and ...

#39. Repatha® (evolocumab) - Prior Authorization/Medical Necessity

Repatha ® (evolocumab) is a PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) inhibitor antibody indicated:.

#40. FDA Approves Repatha® (evolocumab) In Pediatric Patients ...

Repatha binds to PCSK9 and inhibits circulating PCSK9 from binding to the low-density lipoprotein (LDL) receptor (LDLR), preventing PCSK9- ...

#41. Amgen's Repatha clears blocked arteries, shows study

Amgen has presented clinical data indicating that its PCSK9 inhibitor Repatha could help to reverse heart disease by removing ...

#42. New Data Support Long-Term Efficacy of Repatha, But ...

Evolocumab (Repatha) consistently reduced low-density lipoprotein cholesterol in high-risk patients over time.

#43. Repatha, INN-evolocumab - CIMA

Repatha 140 mg solución inyectable en pluma precargada ... Repatha está indicado en adultos con enfermedad cardiovascular aterosclerótica establecida ...

#44. FDA Approves Evolocumab (Repatha) for Certain Patients ...

Repatha is the second drug in its class to be approved in the United States. The FDA approved alirocumab (praluent), produced by Sanofi and ...

#45. Repatha (Evolocumab) for the Treatment of Heterozygous and ...

Repatha (evolocumab) is a new cholesterol lowering injection developed by Amgen that was approved by US Food and Drug Administration (FDA) as an adjunctive ...

#46. No surprise: Repatha reality is messier than initial reports ...

“[Repatha] over about two years of study, reduced the risk of cardiovascular events, including heart attacks and stroke, by about 15 percent.

#47. evolocumab (Repatha) - Scottish Medicines Consortium

evolocumab (Repatha®) is accepted for restricted use within NHS Scotland. · Indication under review: in adults with primary hypercholesterolaemia ...

#48. Amgen Makes Repatha® (Evolocumab) Available In The US ...

The 27,564-patient Repatha cardiovascular outcomes study (FOURIER) demonstrated that adding Repatha to optimized statin therapy resulted in a ...

#49. Amgen's money-back offer on Repatha isn't all that meaningful ...

Repatha, along with Sanofi SA and Regeneron Pharmaceuticals Inc.'s rival PCSK9 inhibitor Praluent, carry list prices of roughly $14,000 a year — ...

#50. Amgen Cuts Repatha's Price By 60 Percent. Will Value-Based ...

Recently, Amgen announced a 60 percent reduction in the list price of its PCSK9 drug Repatha for patients with statin-resistant elevated ...

#51. Notice Regarding Repatha Replacement - HRSA

In October 2018 Amgen announced that it was making Repatha® (evolovumab) available at a reduced list price by introducing new National Drug Codes (NDCs).

#52. Repatha outcomes data "less than stellar" - PMLiVE

Repatha. Amgen believes it has the cardiovascular outcomes data it needs to inject some renewed momentum into its laggard ...

#53. REPATHA (evolocumab), anti-PCSK9 - Haute Autorité de Santé

REPATHA has MA in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, homozygous familial ...

#54. Amgen's Repatha effective; question is for which patients: FDA

Amgen Inc's experimental drug Repatha lowered cholesterol in clinical trials and did not cause a marked disparity in deaths or serious ...

#55. Repatha will only be sold at lower US price in 2020, says Amgen

US biotech Amgen has said that, from December 31, 2019, its PCSK9 inhibitor Repatha (evolocumab) will be available exclusively at its lower ...

#56. FDA Approves Repatha, Amgen's PCSK9 Inhibitor - BioPharm ...

27, 2015 that it approved Repatha (evolocumab), Amgen's PCSK9 inhibitor for the treatment of heterozygous familial hypercholesterolemia ...

#57. Repatha, evolocumab, dru407 - MyPrime.com

Evolocumab (Repatha) is a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor used in the treatment of atherosclerotic cardiovascular disease ...

#58. FDA Grants Priority Review For Amgen's sBLA For Repatha

17 and simultaneously published in the New England Journal of Medicine, showed that adding Repatha to optimized statin therapy provided a 20 ...

#59. Repatha® (evolocumab): High Cholesterol Medication

Repatha ® es un medicamento inyectable de venta con receta que se utiliza: ... En adultos con enfermedad cardiovascular para reducir el riesgo de ataque cardíaco y ...

#60. REPATHA - VIDAL

Dans quel cas le médicament REPATHA est-il prescrit ? ... Ce médicament contient un anticorps monoclonal produit par biotechnologie. Il est conçu ...

#61. Evolocumab (Repatha) - Western Health Advantage

Evolocumab (Repatha®). SELF ADMINISTRATION- INJECTABLE. Indications for Prior Authorization: Indicated to reduce the risk of myocardial ...

#62. Repatha Pushtronex - A New Evolocumab Injection Device

The PCSK9 inhibitor evolocumab (Repatha – Amgen) is now available in a single-dose, hands-free device (Repatha Pushtronex) for once-monthly ...

#63. What You Need to Know About the Heart Drug Repatha

A study in the New England Journal of Medicine found people taking cholesterol-lowering drug Repatha cut their risk of heart attack and ...

#64. REPATHA (evolocumab) RATIONALE FOR INCLUSION IN PA ...

blood, thereby lowering LDL cholesterol levels (1). Regulatory Status. FDA-approved indications: Repatha is a PCSK9 (Proprotein Convertase Subtilisin Kexin Type ...

#65. Could a new drug help reverse heart disease? - CBS News

Statins such as Lipitor and Crestor curb cholesterol production. Repatha and a similar drug, Praluent, block PCSK9, a substance that interferes ...

#66. Repatha™ the first and only PCSK9 Inhibitor now available in ...

Repatha ™ (evolocumab) is a patented product of Amgen global, indicated for the treatment of adult patients with primary hypercholesterolaemia (heterozygous ...

#67. Praluent vs Repatha: Main Differences and Similarities

Praluent and Repatha are injectable drugs used to treat lower LDL-cholesterol (LDL-C) in those with hypercholesterolemia, ...

#68. VCU - Repatha - Patented Medicine Prices Review Board

1.1 Repatha (evolocumab) 140 mg/syringe (Repatha) is indicated as an adjunct to diet and maximally tolerated statin therapy in adult ...

#69. PCSK9 Inhibitors - HSE.ie

Repatha (evolocumab) 140 mg solution for injection in Sureclick pre-filled pen is available under the High Tech Arrangement from 1 July 2019.

#70. Disappointment Hits as Amgen's Repatha Prevents Heart ...

Repatha is a new class of cholesterol drug, a PCSK9 inhibitor. It blocks PCSK9, which affects the liver's ability to remove cholesterol from the ...

#71. Repatha (Evolocumab) - Side Effects, Interactions, Uses ...

Repatha (Evolocumab) ... Evolocumab works by helping the liver reduce levels of "bad" cholesterol (low-density lipoprotein, or LDL) circulating in ...

#72. FDA Approvals Roundup: Qulipta, Repatha, Erbitux | RAPS

New approvals · Qulipta approved as preventive treatment of migraine · New indications · Repatha use extended for adolescents with rare forms of ...

#73. Repatha (evolocumab) - CenterWatch

Approved August of 2015 for the use in adults with heterozygous familial hypercholesterolemia (HeFH), homozygous familial hypercholesterolemia (HoFH), ...

#74. CRITERIA FOR DRUG COVERAGE Evolocumab (REPATHA)

Non-formulary evolocumab (REPATHA) will be covered on the prescription drug benefit when the following criteria are met: Clinical ASCVD (examples include: ...

#75. Clinical Policy: Evolocumab (Repatha) - Health Net

Evolocumab (Repatha®) is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor antibody. FDA Approved Indication(s). Repatha is indicated:.

#76. Repatha | FierceBiotech

The Medicines Company reported that its PCSK9 drug, inclisiran, cut "bad" LDL cholesterol in patients with plaque buildup in their arteries. by Amirah Al Idrus ...

#77. 瑞百安注射液Repatha Solution for Injection-藥品(物)/適應症查詢

預防心血管事件：對於已確診心血管疾病的成年病人，REPATHA可用於降低心肌梗塞、中風及冠狀動脈血管重建術的風險。2. 原發性高脂血症（包含異合子家族 ...

#78. Evolocumab - an overview | ScienceDirect Topics

The package label of evolocumab (Repatha®) disclosed the drug-drug interaction where coadministered statins reduced evolocumab exposure.

#79. Evolocumab (Repatha®) - MotherToBaby

Evolocumab (Repatha®). February 1, 2021. This sheet is about exposure to evolocumab in a pregnancy and while breastfeeding. This information should not take ...

#80. Repatha | Drug Information | PDR.net

Home /; Repatha Drug Information. Drug Information. Repatha. (evolocumab). Install PDR's official, FREE drug information and comparison app today!

#81. Evolocumab - KEGG DRUG

Repatha (TN). Product. REPATHA (Amgen), REPATHA (Amgen USA). Formula. C6242H9648N1668O1996S56. Exact mass. 141700.9089. Mol weight. 141789.0125. Sequence.

#82. Repatha Amgen - Felleskatalogen Pasientutgave

Repatha er et legemiddel som senker nivået av "dårlig" kolesterol, en type fett, i blodet. Repatha inneholder virkestoffet evolokumab, et ...

#83. Repatha Ready Intake Form (ICD-10) - Sterling Specialty ...

Fax Completed Form and/or Copy of Insurance Card(s), Front and Back, to RepathaReady™: 1-855-REPATHA (1-855-737-2842).

#84. 膽固醇難控制美通過注射型新藥Repatha - 奇摩股市

（中央社華盛頓27日綜合外電報導）美國食品暨藥物管理局（FDA）今天通過新型膽固醇藥物Repatha，這是針對頑固型高血脂患者的第2款注射型降血脂藥物...

#85. Evolocumab (REPATHA®) - National Drug Monograph

Evolocumab (REPATHA®) is a humanized monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 (PCSK9).

#86. REPATHA (PCSK9 INHIBITORS) - MedStar Health

Evolocumab (Repatha) must be prescribed by or in consultation with a cardiologist or lipid specialist. AND. 3. There must be clinical documentation of one of ...

#87. GVS-advies evolocumab (Repatha®) herbeoordeling ...

Evolocumab (Repatha®) is in 2016, na advies van het Zorginstituut, opgenomen in het Geneesmiddelenvergoedingssysteem (GVS) op bijlage 1A ...

#88. 成分：Evolocumab 140mg/ml/set 適應症：高血脂症儲存方式

Repatha injection. 從包裝盒取出Repatha預充. 填注射筆，等待至少30分鐘. ，使其自然回復到室溫。 檢查注射筆視窗內的. 液體是否澄清(無色至.

#89. 瑞百安注射液的功效 - 康健知識庫

Repatha Solution for Injection，點擊看用法用量及副作用。適應症：1. 預防心血管事件：對於已確診心血管疾病的成年病人，REPATHA可用於降低心肌梗塞、中風及冠狀動脈 ...

#90. Repatha (Evolocumab): Second PCSK9 Inhibitor Approved by ...

"Repatha provides another treatment option in this new class of drugs for patients with familial hypercholesterolemia or with known cardiovascular disease who ...

#91. New Drug Update - Repatha (Evolocumab) - AlixaRx

Approved by the FDA in August 2015, Repatha (Evolocumab) is a medication used to treat high LDL (low density lipoprotein) cholesterol.

#92. g Repatha® Prior Authorization Request Form (Page 1 of 3)

Repatha ® Prior Authorization Request Form (Page 1 of 3). DO NOT COPY FOR FUTURE USE. FORMS ARE UPDATED FREQUENTLY AND MAY BE BARCODED.

#93. Cholesterol drug prevents heart attacks — but costs $14K a year

Repatha, a man-made antibody also known as evolocumab, cut the combined risk of heart attack, stroke and cardiovascular-related death in ...

#94. Repatha - News Detail | Harvard Pilgrim Health Care

Repatha works differently than statin drugs that prevent the liver from making cholesterol. Given by injection every two or four weeks, Repatha ...

#95. Repatha® SC Injection 420 mg Auto Mini Doser Launched in ...

Repatha ® is the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor in Japan for the treatment of patients with familial ...